Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-047813
Filing Date
2023-08-31
Accepted
2023-08-31 14:23:13
Documents
1
Period of Report
2023-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11998
  Complete submission text file 0001209191-23-047813.txt   13461
Mailing Address 1001 SANTERRE DRIVE GRAND PRAIRIE TX 75050
Business Address
AUERBACH MARK (Reporting) CIK: 0001018007 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40067 | Film No.: 231228350

Mailing Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008 415-649-8758
PARDES BIOSCIENCES, INC. (Issuer) CIK: 0001822711 (see all company filings)

EIN.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations